Organizational Transformation at Wanbang Pharmaceutical Technology

Dongyuan Wu; Guangsheng Yu; Yutong Li; Jieyou Zhang

Product #:FDC-25026-2X-CE_P

Supplier:School of Management at Fudan University

Discipline:Human Resource Management

Setting:China, 2025

Details:Case (PDF) • 18 pages • 2025-07-10 (Rev: 2025-07-10)

Your Price:

$10.54

Language:

Format:

Purchase this material with a free Educator Account and enjoy more benefits:

Free Educator Copy
Free Teaching Notes
Build your coursepack
Discounted academic price

Wanbang Pharmaceutical Technology is a CRO (contract research organization) providing pharmaceutical research and clinical trial services. After two industry shocks and an internal reorganization, the company grew rapidly and went public on the Shenzhen ChiNext board in 2023. Founder Chunlei Tao now hopes to leverage the listing to attract talent, energize the organization, and steer the company’s transformation from a traditional CRO toward the broader healthcare sector. How should Wanbang design an organization that aligns with this strategic transitio

Learning Objectives

This case is designed to help students understand how organizational design and corporate culture shape team management, and how firms can redesign their organizations to support strategic change as they grow. It is suitable for MBA and EMBA teaching as well as executive education, and can be used in courses on strategic management, human resource management, and organizational behavior. The specific teaching objectives are as follows: 1. Help students understand how strategy shapes organizational design 2. Examine the impact of transformational leadership on firm development 3. Familiarize students with the core frameworks of organizational design

Organizational Transformation at Wanbang Pharmaceutical Technology

Subjects:

Industries:

Geography:

Learning Objectives